From: PETERS, JENNY L [R&D/0200] [jenny.l.peters@pharmacia.com]
Sent: Friday, September 20, 2002 11:27 AM
To: 'fdadockets@oc.fda.gov'
Subject: Docket 00N-1663

Docket No. 00N-1663; Proposed Rule, Investigational New Drugs: Export
Requirements for Unapproved New Drug Products; 67 Federal Register 41642
(June
19, 2002)

We have reviewed and agree with the comments submitted by PhRMA on 17
September 2002.  We congratulate FDA for taking the initiative to propose
amending its regulations for exporting investigational new drugs so that
they include mechanisms which are simpler while still taking into account
public health concerns.  

Jenny L. Peters
Pharmacia
Director, Global Regulatory Affairs
616.833.8141 phone
616.833.0512 fax
jenny.l.peters@pharmacia.com